A Kentwood plant passes the audit that mattered

NN, Inc., a Charlotte-based industrial components supplier, secured its first purchase orders to manufacture precision parts for a leading robotic-assisted surgery platform. The deal came after the company passed a critical full-facility audit at its Kentwood, Michigan plant, according to a press release issued Monday.

The audit was the hardest step in NN's effort to break into the robotic surgery market, the company said. A multi-year investment program and a new quality system made the pass possible.

What the deal means for Kentwood

NN's medical new business pipeline grew by approximately $25 million because of the win, bringing the total to around $75 million, according to the company. That figure represents a meaningful piece of NN's total corporate new business pipeline, which exceeded $750 million across all markets.

"This is a milestone event for NN's medical products growth program and a direct payoff on the investments we have made over the last three years to establish a premier presence in this medical market."

That quote came from Harold Bevis, president and chief executive officer of NN, Inc. He said the company upgraded its quality system to the medical level and now has a qualified supplier status with a major customer.

The Kentwood facility will handle immediate delivery and ramp-up requirements for the new purchase orders, according to the release.

Why robotic surgery matters

Robotic-assisted surgery is the fastest-growing method of surgical care in the United States, expanding at double-digit annual rates, NN said in its statement. The market presents a strong growth opportunity for precision component suppliers that have the engineering capability and quality systems to serve it.

NN said it is actively investing in the medical market with dedicated staff, additional equipment, and attendance at medical device trade shows.

Stock reaction

Shares of NN (NASDAQ: NNBR) jumped 5.6 percent in morning trading after the announcement, according to Yahoo Finance reporter Adam Hejl. The stock cooled to $3.61 per share, up 4.4 percent from the previous close. NN shares are up 169 percent since the beginning of the year and set a new 52-week high on Monday.

The stock had dropped 13.9 percent four days earlier after the company announced it raised $75 million through a private placement of common stock, Hejl reported.

What comes next

NN said it will combine the medical product win information with recent wins in data centers and adjust 2026 sales, adjusted EBITDA, and new wins guidance if needed. The company plans to update guidance during its next business and guidance update in August, according to Bevis.

Bevis called the medical products achievement consistent with NN's broader growth program. He listed five pillars of breakout growth: data center and electric grid, defense and electronics, medical products, high-value vehicle products, and high-value stamped products.